Controlling cytokine signaling by constitutive inhibitors

被引:96
作者
Rakesh, K
Agrawal, DK [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Internal Med, Omaha, NE 68178 USA
[3] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA
关键词
cytokines; JAK/STAT signalling; SOCS; SHP; PIAS; inhibitors of signaling;
D O I
10.1016/j.bcp.2005.04.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytokines are secreted proteins that regulate diverse biological functions by binding to receptors at the cell surface to activate complex signal transduction pathways including the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. Stringent mechanisms of signal attenuation are essential for ensuring an appropriate, controlled cellular response. Three families of proteins, the SH2-containing phosphatases (SHP), the protein inhibitors of activated STATs (PIAS), and the suppressors of cytokine signaling (SOCS), inhibit specific and distinct aspects of cytokine signal transduction. The analysis of mice lacking genes for members of the SHP has shed much light on the roles of these proteins in vivo. In recent in vitro studies, the protein modifiers ubiquitin and small ubiquitin-like modifier (SUMO) have emerged as key players in the strategies employed by SOCS and PIAS to repress signaling. This review throws light on the mechanisms of action of these regulators as being evolved by the latest researches. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 50 条
[41]   Regulation of JAK-STAT signalling in the immune system [J].
Shuai, K ;
Liu, B .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (11) :900-911
[42]   Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia [J].
Tartaglia, M ;
Martinelli, S ;
Cazzaniga, G ;
Cordeddu, V ;
Iavarone, I ;
Spinelli, M ;
Palmi, C ;
Carta, C ;
Pession, A ;
Aricò, M ;
Masera, G ;
Basso, G ;
Sorcini, M ;
Gelb, BD ;
Biondi, A .
BLOOD, 2004, 104 (02) :307-313
[43]   Molecular mechanisms underlying SHP-1 gene expression [J].
Tsui, HW ;
Hasselblatt, K ;
Martin, A ;
Mok, SC ;
Tsui, FWL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (12) :3057-3064
[44]  
Wang LM, 2004, ONCOL REP, V11, P1319
[45]  
Ward AC, 2000, BLOOD, V95, P19
[46]   Protein inhibitor of activated STAT y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life [J].
Wong, KA ;
Kim, R ;
Christofk, H ;
Gao, J ;
Lawson, G ;
Wu, H .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (12) :5577-5586
[47]   The function of the protein tyrosine phosphatase SHP-1 in cancer [J].
Wu, CY ;
Sun, MZ ;
Liu, LJ ;
Zhou, GW .
GENE, 2003, 306 :1-12
[48]   Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter [J].
Zhang, Q ;
Raghunath, PN ;
Vonderheid, E ;
Odum, N ;
Wasik, MA .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1137-1146
[49]   Loss of SHP-1 phosphatase alters cytokine expression in the mouse hindbrain following cochlear ablation [J].
Zhao, H ;
Lurie, DI .
CYTOKINE, 2004, 28 (01) :1-9
[50]  
Zheng Y, 2004, ACTA PHARMACOL SIN, V25, P1058